GAL and epilepsy: Using lentivirus, adeno-associated virus, and herpes simplex viral vectors in animal models, the most gene therapies for treatment of epilepsy targeted neurotrophic factors (37), galanin (38), adenosine kinase (39), and neuropeptide Y (40).